Prochlorperazine Edisylate

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1201 publications

Identifying candidate therapeutic targets in amyotrophic lateral sclerosis through a transcriptome-wide machine-learning consensus approach for drug repurposing.

Identifying candidate therapeutic targets in amyotrophic lateral sclerosis through a transcriptome-wide machine-learning consensus approach for drug repurposing.

Journal: Neuroscience
Published: May 27, 2026

Preparation and evaluation of Prochlorperazine Maleate loaded nanostructured lipid carrier for the treatment of schizophrenia.

Preparation and evaluation of Prochlorperazine Maleate loaded nanostructured lipid carrier for the treatment of schizophrenia.

Journal: Therapeutic delivery
Published: May 22, 2026

Prochlorperazine inhibits the proliferation of hepatocellular carcinoma cells by promoting phosphorylation of β-catenin.

Prochlorperazine inhibits the proliferation of hepatocellular carcinoma cells by promoting phosphorylation of β-catenin.

Journal: Anti-cancer drugs
Published: March 05, 2026

Successful use of intravenous droperidol in hyperemesis following failure of sequential antiemetic therapy.

Successful use of intravenous droperidol in hyperemesis following failure of sequential antiemetic therapy.

Journal: The American journal of emergency medicine
Published: March 04, 2026

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF).

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF).

Journal: The journal of headache and pain
Published: February 04, 2026

Trends in Antipsychotic Drug Use in the United States, 2000-2016.

Trends in Antipsychotic Drug Use in the United States, 2000-2016.

Journal: Pharmacy (Basel, Switzerland)
Published: December 01, 2025

Exploring Risk Drugs and Mechanisms in Dystonia: Insights from Pharmacovigilance and Proteogenomics.

Exploring Risk Drugs and Mechanisms in Dystonia: Insights from Pharmacovigilance and Proteogenomics.

Journal: Current neuropharmacology
Published: October 14, 2025

Identifying High-Risk Medications for Drug-Induced Dystonia: A 20-Year Retrospective Real-World Pharmacovigilance Study Based on FAERS.

Identifying High-Risk Medications for Drug-Induced Dystonia: A 20-Year Retrospective Real-World Pharmacovigilance Study Based on FAERS.

Journal: Health science reports
Published: September 04, 2025

A glycoengineered anti-ROR1 antibody, GE-zilovertamab, selectively enhances antibody-dependent cellular cytotoxicity against chronic lymphocytic leukemia.

A glycoengineered anti-ROR1 antibody, GE-zilovertamab, selectively enhances antibody-dependent cellular cytotoxicity against chronic lymphocytic leukemia.

Journal: Antibody therapeutics
Published: September 03, 2025

Investigating Potential Prescribing Cascades Resulting in Prochlorperazine Prescription: An Exploratory Analysis of Antihypertensives and NSAIDs.

Investigating Potential Prescribing Cascades Resulting in Prochlorperazine Prescription: An Exploratory Analysis of Antihypertensives and NSAIDs.

Journal: Drugs & aging
Published: August 19, 2025

Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report.

Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report.

Journal: Cureus
Published: August 19, 2025

Prochlorperazine dimaleate elicits antiproliferative activity of gastric cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway.

Prochlorperazine dimaleate elicits antiproliferative activity of gastric cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway.

Journal: Genes & diseases
Published: August 13, 2025
Showing 1-12 of 1,201

Last Updated: 09/26/2026